These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 2571671

  • 1. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
    Hsu WS, Kao JT, Chen JS.
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic renal tubular effects in relation to urine cadmium levels.
    Mueller PW, Smith SJ, Steinberg KK, Thun MJ.
    Nephron; 1989 Apr; 52(1):45-54. PubMed ID: 2565539
    [Abstract] [Full Text] [Related]

  • 4. [Urinary enzymes: early biochemical indicators in the biological monitoring study of subjects exposed to styrene].
    Malaguti Aliberti L, Severini GC.
    Minerva Med; 1989 Apr; 80(4):383-8. PubMed ID: 2566961
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin.
    Gibey R, Dupond JL, Alber D, Leconte des Floris R, Henry JC.
    Clin Chim Acta; 1981 Oct 08; 116(1):25-34. PubMed ID: 6172216
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic effects and influence on the urinary enzyme activity of human urinary trypsin inhibitor (urinastatin) in cases with acute renal failure--changes in the urinary activities of NAG and AAP].
    Soejima A, Suzuki M, Kamiya K, Motohasi S, Nakabayashi K, Kitamoto K, Nagasawa T.
    Nihon Jinzo Gakkai Shi; 1989 Sep 08; 31(9):985-90. PubMed ID: 2573748
    [Abstract] [Full Text] [Related]

  • 8. [Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma].
    Kitamura Y, Watanabe M, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1990 May 08; 36(5):535-9. PubMed ID: 1698011
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase during pregnancy.
    Strigini F, Melis GB, Gasperini M, Ronca G, Palmieri L, Fioretti P.
    Int J Gynaecol Obstet; 1989 Jan 08; 28(1):9-12. PubMed ID: 2565837
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP)].
    Bertotti A, De Marchi S, Brovedani P, Gaeta G, Peratoner L, Mangiarotti MA.
    Pediatr Med Chir; 1990 Jan 08; 12(4):347-9. PubMed ID: 1981610
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
    Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H.
    Clin Chim Acta; 1981 May 05; 112(2):149-57. PubMed ID: 6113066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
    Kunin CM, Chesney RW, Craig WA, England AC, DeAngelis C.
    Pediatrics; 1978 Nov 05; 62(5):751-60. PubMed ID: 364392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.